The Hsp90 Inhibitor 17-DMAG Attenuates Hyperglycemia-Enhanced Hemorrhagic Transformation in Experimental Stroke.

Published in: BioMed research international (2021)

These results implicated that Hsp90 could be a novel therapeutic target in HT following ischemic stroke.

Keyphrases